Skip to main
CLBT

CLBT Stock Forecast & Price Target

CLBT Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 80%
Buy 20%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Cellebrite DI is a leading provider of AI-powered digital investigative solutions, assisting both public and private sector clients. With a strong focus on law enforcement and defense, Cellebrite has achieved significant revenue growth and is poised for continued success with the introduction of new products and expansion into new markets. While there are risks associated with security breaches and geopolitical uncertainty, Cellebrite's financial strength and ethical stance on human rights and data security make them a promising investment opportunity.

Bears say

Cellebrite DI is in a competitive market facing intense pricing pressures,and although it has a strong customer base, its dependence on law enforcement and government agencies may lead to future growth risksdue to budgeting cycles and shifts in spending priorities. Additionally, the risk of a breach on its solutions and data poses a reputational and financial risk that could negatively affect the company. Its high EBITDA and FCF margins make it attractive, but there are concerns about its outlook for EBITDA margin and fluctuations in foreign currency that could impact its competitiveness. The market for digital forensics and intelligence solutions is large, but their ability to cross-sell and upsell existing customers will be crucial for future growth.

CLBT has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 80% of analysts recommend a Strong Buy, 20% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cellebrite DI Ltd and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cellebrite DI Ltd (CLBT) Forecast

Analysts have given CLBT a Strong Buy based on their latest research and market trends.

According to 5 analysts, CLBT has a Strong Buy consensus rating as of Jul 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cellebrite DI Ltd (CLBT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.